2006
DOI: 10.1080/j.1440-1614.2006.01903.x
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence, Interference with Life and Severity of 12 Month DSM-IV Disorders in Te Rau Hinengaro: The New Zealand Mental Health Survey

Abstract: Compared with other World Mental Health survey sites New Zealand has relatively high prevalences, although almost always a little lower than for the US. For all disorders, except specific phobia, interference with life was reported to be moderate, on average, which has lead to less than a third of cases being classified as mild. Most people who have ever met full DSM-IV criteria, including the impairment criterion, and who experience symptoms or an episode in the past 12 months find that their disorders impact… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
80
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 158 publications
(93 citation statements)
references
References 19 publications
13
80
0
Order By: Relevance
“…Consistent with findings from other general population studies (Hay et al, 2008;Hudson et al, 2007;Wells et al, 2006), there were no participants who currently met criteria for AN. The participants were highly symptomatic at inception but only 3% were in treatment for their eating problems.…”
Section: Discussionsupporting
confidence: 87%
“…Consistent with findings from other general population studies (Hay et al, 2008;Hudson et al, 2007;Wells et al, 2006), there were no participants who currently met criteria for AN. The participants were highly symptomatic at inception but only 3% were in treatment for their eating problems.…”
Section: Discussionsupporting
confidence: 87%
“…The past-year prevalence of MDD was lower than several other recent surveys, such as the US National Comorbidity Survey Replication (6.6%) 12 and the New Zealand Te Rau Hinengaro (5.7%). 13 In highincome countries, past-year prevalence estimates in the WMH Surveys Initiative included some lower estimates as well; for example, 2.2% in Japan and 3.0% in Germany. 5 Systematic reviews for the Global Burden of Disease Studies placed the point prevalence of MDD at 3.7% (95% uncertainty interval 3.1% to 4.3%), 14 similar to the 12-month prevalence reported here.…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of major depressive disorder (MDD) in the general population has frequently been found to decrease with increasing age (Regier et al 1988;Karel, 1997;Beekman et al 1999;Kessler et al 2003a;Alonso et al 2004;Pirkola et al 2005;Wells et al 2006;Troller et al 2007), and the picture for anxiety disorders is similar (Regier et al 1988;Jorm, 2000;Alonso et al 2004;Wells et al 2006;Troller et al 2007). A number of methodological reasons have been advanced for this, including selective mortality, excluding the institutionalized from the sample and cohort effects (Karel, 1997;Jorm, 2000;Snowdon, 2001;Hybels & Blazer, 2002;O'Connor, 2006).…”
Section: Introductionmentioning
confidence: 99%